HUMACYTE AT ASN KIDNEY WEEK: PHASE 3 TRIAL BUILT FOR WOMEN SHOWS ATEV ADVANTAGE OVER FISTULA, GETTING PATIENTS OFF CATHETERS MONTHS SOONER

Reuters · 3d ago

Please log in to view news